Allscripts Healthcare Solutions (MDRX)




Faruqi & Faruqi, LLP Announces Investigation of Allscripts Healthcare Solutions, Inc.

Faruqi & Faruqi, LLP, is investigating potential securities fraud at Allscripts Healthcare Solutions, Inc. (“Allscripts” or the “Company”) (Nasdaq: MDRX).  

The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that:  (1) the process of developing a unified product offering after the Company’s merger with Eclypsis was difficult and costly; (2) merger-related difficulties would cause upheaval and result in the loss of key Company personnel; and (3) substantial Company business had been destroyed by Allscripts’ inability to successfully integrate Eclypsis’ systems with its own.

On April 26, 2012, Allscripts issued operating results for the first quarter of 2012 that were well below expected forecasts. The Company also announced the termination of the Chairman of the Board and the resignation of three Company directors and the Company’s Chief Financial Officer.  In light of these turbulent events, Allscripts’ stock price fell $5.72 per share, or 35.7 percent, to close at $10.30 per share on April 27, 2012.


Request Information

  Please tell us about yourself by completing the form and we will provide you with additional
information on how to join the Class Action at no cost to you. If you want to be a Lead Plaintiff or join
this action now, please click HERE.

Case:Allscripts Healthcare Solutions (MDRX)
*Security code:

*The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello

Faruqi & Faruqi, LLP
369 Lexington Avenue 10th Floor
New York, NY 10017
Tel: (212) 983-9330

Send Information

If you have information regarding this case that you would
like to make available, please click here to contact us
about our investigation

Case Details